Tumor necrosis factor-α drives HIV-1 replication in U937 cell clones and upregulates CXCR4

被引:19
作者
Biswas, P
Mantelli, B
Delfanti, F
Cota, M
Vallanti, G
De Filippi, C
Mengozzi, M
Vicenzi, E
Lazzarin, A
Poli, G
机构
[1] Dept Infect Dis, Clin Immunol Lab, I-20127 Milan, Italy
[2] Hosp San Raffaele, Inst Sci, AIDS Immunopathogenesis Unit, I-20132 Milan, Italy
关键词
CXCR4; HIV-1; U937; TNF-alpha;
D O I
10.1006/cyto.2000.0798
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
U937 cell clones in which efficient (plus) vs poor (minus) replication of HIV-1 occurs have been described. We evaluated the role of host factors in their differential ability to support HIV-1 replication. Plus clones constitutively produced TNF-alpha and viral replication was inhibited by neutralization of endogenous TNF-alpha, However, HIV-I replication was strongly upregulated in minus clones by exogenous TNF-alpha, which also further accelerated the kinetics of infection in plus clones, We observed an increased accumulation of proviral DNA within one round of HIV-I replication following TNF-alpha treatment of plus cells, This effect was associated with increased surface density of CXCR4 in both plus and minus clones. Our results identify TNF-alpha as one correlate that contributes to the higher ability of U937-plus clones to sustain HIV-1 replication, Furthermore, we suggest that TNF-alpha may affect steps of the viral life cycle that occur earlier than transcription and also enhance HIV-I replication by increasing the surface density of CXCR4. (C) 2001 Academic Press.
引用
收藏
页码:55 / 59
页数:5
相关论文
共 14 条
[1]   SUSCEPTIBILITY TO INFECTION BY THE HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) CORRELATES WITH T4 EXPRESSION IN A PARENTAL MONOCYTOID CELL-LINE AND ITS SUBCLONES [J].
ASJO, B ;
IVHED, I ;
GIDLUND, M ;
FUERSTENBERG, S ;
FENYO, EM ;
NILSSON, K ;
WIGZELL, H .
VIROLOGY, 1987, 157 (02) :359-365
[2]   1,25-dihydroxyvitamin D3 upregulates functional CXCR4 human immunodeficiency virus type 1 coreceptors in U937 minus clones:: NF-ΚB-independent enhancement of viral replication [J].
Biswas, P ;
Mengozzi, M ;
Mantelli, B ;
Delfanti, F ;
Brambilla, A ;
Vicenzi, E ;
Poli, G .
JOURNAL OF VIROLOGY, 1998, 72 (10) :8380-8383
[3]   DIFFERENTIAL SUSCEPTIBILITIES OF U-937 CELL CLONES TO INFECTION BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
BOULERICE, F ;
GELEZIUNAS, R ;
BOUR, S ;
LI, HL ;
DADDARIO, M ;
ROULSTON, A ;
HISCOTT, J ;
WAINBERG, MA .
JOURNAL OF VIROLOGY, 1992, 66 (02) :1183-1187
[4]   Endothelial cells differentially express functional CXC-chemokine receptor-4 (CXCR-4/fusin) under the control of autocrine activity and exogenous cytokines [J].
Feil, C ;
Augustin, HG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 247 (01) :38-45
[5]   A FAMILY OF SERINE PROTEASES EXPRESSED EXCLUSIVELY IN MYELO-MONOCYTIC CELLS SPECIFICALLY PROCESSES THE NUCLEAR FACTOR-KAPPA-B SUBUNIT P65 IN-VITRO AND MAY IMPAIR HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION IN THESE CELLS [J].
FRANZOSO, G ;
BISWAS, P ;
POLI, G ;
CARLSON, LM ;
BROWN, KD ;
TOMITAYAMAGUCHI, M ;
FAUCI, AS ;
SIEBENLIST, UK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1445-1456
[6]  
KINTER AL, 1995, J IMMUNOL, V154, P2448
[7]   INCREASED HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) EXPRESSION IN CHRONICALLY INFECTED U937 CELLS UPON INVITRO DIFFERENTIATION BY HYDROXYVITAMIN-D3 - ROLES OF INTERFERON AND TUMOR-NECROSIS-FACTOR IN REGULATION OF HIV PRODUCTION [J].
LOCARDI, C ;
PETRINI, C ;
BOCCOLI, G ;
TESTA, U ;
DIEFFENBACH, C ;
BUTTO, S ;
BELARDELLI, F .
JOURNAL OF VIROLOGY, 1990, 64 (12) :5874-5882
[8]   TUMOR-NECROSIS-FACTOR-ALPHA CACHECTIN ENHANCES HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION IN PRIMARY MACROPHAGES [J].
MELLORS, JW ;
GRIFFITH, BP ;
ORTIZ, MA ;
LANDRY, ML ;
RYAN, JL .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (01) :78-82
[9]   Promonocytic U937 subclones expressing CD4 and CXCR4 are resistant to infection with and cell-to-cell fusion by T-cell-tropic human immunodeficiency virus type 1 [J].
Moriuchi, H ;
Moriuchi, M ;
Arthos, J ;
Hoxie, J ;
Fauci, AS .
JOURNAL OF VIROLOGY, 1997, 71 (12) :9664-9671
[10]  
Moriuchi M, 1997, J IMMUNOL, V159, P4322